Prescriber Compliance With Liver Monitoring Guidelines for Pazopanib in the Postapproval Setting: Results From a Distributed Research Network.

Journal Information

Full Title: J Patient Saf

Abbreviation: J Patient Saf

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Health Services

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure of Potential Conflicts of Interest: S.S. and J.J.N. were employees and owned stock in GlaxoSmithKline at the time that the study was designed and executed. M.P.P.v.H.-S. is an employee of the PHARMO Institute. This independent research institute performs financially supported studies for government and related health-care authorities and several pharmaceutical companies. B.L.N. is an employee of Evidera, which received funding from GSK for this study. S.A.H. was an employee of New England Research Institutes, which received funding from GSK for this study."

Evidence found in paper:

"Disclosure of Potential Conflicts of Interest: S.S. and J.J.N. were employees and owned stock in GlaxoSmithKline at the time that the study was designed and executed. M.P.P.v.H.-S. is an employee of the PHARMO Institute. This independent research institute performs financially supported studies for government and related health-care authorities and several pharmaceutical companies. B.L.N. is an employee of Evidera, which received funding from GSK for this study. S.A.H. was an employee of New England Research Institutes, which received funding from GSK for this study. This study was funded by GlaxoSmithKline."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025